Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis

Clinical Rheumatology

Volumn 27, Issue 3, 2008, Pages 315-322

  Mok, Mo Yin ^a,b   Fung, Peter Chin Wah ^a   Ooi, Clara ^a   Tse, Hung Fat ^a   Wong, Yik ^a   Lam, Yui Ming ^a   Wong, Woon Sing ^a   Lau, Chak Sing ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Inflammation; Interstitial lung disease; Nitric oxide synthase; Systemic sclerosis

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; NITRATE; NITRIC OXIDE; NITRITE; PENICILLAMINE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; ARTHROPATHY; ARTICLE; CARDIOVASCULAR DISEASE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DYSPHAGIA; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; KIDNEY DISEASE; LIVER DISEASE; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; ONSET AGE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; STOMACH ACID SECRETION; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; CASE CONTROL STUDY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PREDNISOLONE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 41949135420     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0708-9     Document Type: Article

References (33)

1. Black CM, du Bois RM. Organ involvement: pulmonary. In: Clements PJ, Furst D (eds) Systemic sclerosis. Williams & Wilkins, pp 299-331
2. PJ Clements PA Lachenbruch JR Seibold, et al. 1993 Skin thickness score in systemic sclerosis: an assessment of inter-observer variability in three independent studies J Rheumatol 20 1892 1896 8308774 1:STN:280:ByuC2c7nvFU%3D
3. VD Steen TA Medsger Jr 2001 Improvement in skin thickening in systemic sclerosis associated with improved survival Arthritis Rheum 44 2828 2835 11762943 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U 1:STN:280:DC%2BD38%2FjslGmug%3D%3D (Pubitemid 34016202)
4. RM Palmer AG Ferriage S Moncada 1987 Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524 526 3495737 10.1038/327524a0 1:CAS:528:DyaL2sXktlCjs70%3D (Pubitemid 17085822)
5. RM Clancy SB Abramson 1995 Nitric oxide: a novel mediator of inflammation Proc Soc Exp Biol Med 210 93 101 7568290 1:CAS:528:DyaK2MXovVGhtbw%3D
6. SA Cotton AL Herrick MI Jayson, et al. 1999 Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin J Pathol 189 273 278 10547586 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3. 0.CO;2-4 1:CAS:528:DyaK1MXms12mtbY%3D (Pubitemid 29448924)
7. B Kahaleh M Matucci-Cerenic 1995 Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone Arthritis Rheum 38 1 4 7818557 10.1002/art.1780380102 1:STN:280:ByqC3MfjvVY%3D
8. Y Allanore D Borderie P Hilliquin, et al. 2001 Low levels of nitric oxide in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells Rheumatology 40 1089 1096 11600736 10.1093/rheumatology/40.10.1089 1:CAS:528:DC%2BD3MXot1GltbY%3D
9. T Yamamoto I Katayama K Nishioka 1998 Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis J Rheumatol 25 314 317 9489825 1:STN:280:DyaK1c7kvFCluw%3D%3D (Pubitemid 28088261)
10. A Sud M Khullar A Wanchu, et al. 2000 Increased nitric oxide production in patients with systemic sclerosis Nitric Oxide 4 615 619 11139370 10.1006/niox.2000.0309 1:CAS:528:DC%2BD3MXnsVan (Pubitemid 32053273)
11. GN Andersen K Caidahl E Kazzam, et al. 2000 Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis Arthritis Rheum 43 1085 1093 10817563 10.1002/1529-0131(200005)43: 5<1085::AID-ANR19>3.0.CO;2-7 1:CAS:528:DC%2BD3cXjvVeiur0%3D (Pubitemid 30368189)
12. K Takagi Y Kawaguchi M Hara, et al. 2003 Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features Clin Exp Immunol 134 538 544 14632763 10.1111/j.1365-2249.2003.02320.x 1:CAS:528:DC%2BD2cXis1KksA%3D%3D (Pubitemid 37542097)
13. A Dooley B Gao N Bradley, et al. 2006 Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine Rheumatology 45 676 684 16399843 10.1093/rheumatology/kei276 1:CAS:528:DC%2BD28Xmt1Wku70%3D (Pubitemid 43985335)
14. EC LeRoy C Black R Fleishcmajer, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205 3361530 1:STN:280:BieB3c%2FhsVQ%3D
15. M Berger A Haimowitz A Van Tosh, et al. 1985 Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound J Am Coll Cardiol 6 359 365 4019921 1:STN:280:BiqB283js1c%3D
16. 3, in plasma after experimental myocardial infarction J Mol Cell Cardiol 29 1 9 9040016 10.1006/jmcc.1996.9998 1:CAS:528:DyaK2sXhsVWhtbo%3D (Pubitemid 27129125)
17. T Yamamoto Y Sawada I Katayama, et al. 1998 Increased production of nitric oxide stimulated by interleukin-1 beta in peripheral blood mononuclear cells in patients with systemic sclerosis Br J Rheumatol 37 1123 1125 9825753 10.1093/rheumatology/37.10.1123 1:STN:280:DyaK1M%2FktFWjsg%3D%3D
18. MS Gruschwitz G Vieth 1990 Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-γ and tumour necrosis factor α in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 94 197 203 2299195 10.1111/1523-1747. ep12874503 1:CAS:528:DyaK3cXhtlKrs7Y%3D
19. CM Stein SB Tanner JA Awad, et al. 1996 Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma Arthritis Rheum 39 1146 1150 8670323 10.1002/art.1780390711 1:STN:280:BymB28nivVc%3D (Pubitemid 26240227)
20. F Ogawa K Shimizu E Muroi, et al. 2006 Serum levels of 8-isoprostaine, a marker of oxidative stress, are elevated in patients with systemic sclerosis Rheumatology 45 815 818 16449367 10.1093/rheumatology/kel012 1:CAS:528:DC%2BD28Xmt1WrsrY%3D (Pubitemid 43985368)
21. RJ Prescott AJ Freemont CJP Jones, et al. 1992 Sequential dermal microvascular and perivascular changes in the development of scleroderma J Pathol 166 255 263 1517881 10.1002/path.1711660307 1:STN:280:By2A1cbgvVE%3D
22. B Kahaleh PS Fan M Matucci-Cerinic, et al. 1993 Study of endothelial dependent relaxation in scleroderma Arthritis Rheum 36 Suppl 9 S180
23. LI Romero DN Zhang JP Cooke, et al. 2000 Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma Vasc Med 5 147 158 11104297 1:STN:280:DC%2BD3M7lt1aksw%3D%3D
24. P Paredi SA Kharitonov S Loukides, et al. 1999 Exhaled nitric oxide is increased in active fibrosing alveolitis Chest 115 1352 1356 10334152 10.1378/chest.115.5.1352 1:STN:280:DyaK1M3msFehsw%3D%3D (Pubitemid 29230646)
25. D Saleh PJ Barnes A Giad 1997 Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis Am J Resp Crit Care Med 155 1763 1769 9154889 1:STN:280:ByiB1MbnsVQ%3D
26. A Ludwicka T Ohba M Trojanowska, et al. 1995 Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma J Rheumatol 22 1876 1883 8991985 1:CAS:528:DyaK2MXpsVWjsbY%3D
27. Y Vodovotz 1997 Control of NO production by TGFβ1: mechanistic insights and potential relevance to human disease Nitric oxide 1 3 17 9701040 10.1006/niox.1996.0105 1:CAS:528:DyaK2sXislaht70%3D (Pubitemid 28078123)
28. B Stephen P Dalal M Berger, et al. 1999 Noninvasive estimation of pulmonary arterial diastolic pressure in patients with tricuspid regurgitation by doppler echocardiography Chest 116 73 77 10424506 10.1378/chest.116.1.73 1:STN:280:DyaK1MzltFOqsA%3D%3D (Pubitemid 29340263)
29. G Rolla P Colagrande E Scappaticci, et al. 2000 Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension J Rheumatol 27 1693 1698 10914853 1:CAS:528:DC%2BD3cXltlKqsLs%3D
30. S Kharitonov JB Cailes CM Black, et al. 1997 Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension Thorax 52 1051 1055 9516898 1:STN:280:DyaK1c7nslGnsA%3D%3D
31. A Giad D Saleh 1995 Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 213 221
32. RM Clancy AR Amin SB Abramson 1998 The role of nitric oxide in inflammation and immunity Arthritis Rheum 41 1141 1151 9663469 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S 1:CAS:528:DyaK1cXkslWjtL4%3D (Pubitemid 28313414)
33. MM Cerinic MB Kahaleh 2002 Beauty and the beast. The nitric oxide paradox in systemic sclerosis [editorial] Rheumatol 41 843 847 10.1093/rheumatology/41. 8.843